Here are four medical device businesses that displayed healthy growth that you can add to your buy watchlist. Intuitive ...

Highlights,Institutional investors have adjusted their stakes in Inari Medical, contributing to market engagement.,The ...

The wearable cardiac monitor and defibrillator developer Kestra Medical Technologies aims to raise about $154 million by ...

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...

花旗更新后的财务模型考虑了Inari对Stryker业绩的预期贡献。预计Inari在2025年约10个月期间将产生5.9亿美元的收入。尽管预计Inari将使Stryker的营业利润率降低0-20基点，但预计也将为每股收益（EPS）增加0.20至0.30美元。

Citi resumed coverage of Stryker (SYK) with a Buy rating and $450 price target following the close of the Inari acquisition tryker has built a ...

Stryker has completed its $4.9 billion acquisition of Inari Medical, a company specializing in venous thromboembolism ...

Powered by rapid AI advancements, enhanced automation processes, and growing demand for commercial adoption, modern robotics ...

Inari’s expertise combined with Stryker’s existing distribution and logistics network could boost volume and procedure ...

State of New Jersey Common Pension Fund D lessened its holdings in Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 10.6% ...

Stryker Corp. yesterday closed on its $4.9 billion acquisition of Inari Medical Inc., which is now a wholly owned subsidiary ...

Highlights,Asset Management One Co. Ltd. raised its stake in Inari Medical by 7.8% in the fourth quarter, adding 4,795 shares ...